Related Experiment Video
Updated: Feb 11, 2026

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta
Published on: April 3, 2017
Cardiac Restoration Stemming From the Placenta Tree: Insights From Fetal and Perinatal Cell Biology
Sveva Bollini1, Antonietta R Silini2, Asmita Banerjee3
1Regenerative Medicine Laboratory, Department of Experimental Medicine, University of Genova, Genova, Italy.
Insights
Fetal and perinatal stem cells offer promising avenues for cardiac repair and regeneration, addressing limitations of current treatments like heart transplantation. These cells show potential in various therapeutic strategies for heart failure.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Stem Cell Therapy
Background:
- Cardiovascular diseases, including myocardial ischemia/infarction and cardiotoxicity, lead to heart failure.
- Current treatments like heart transplantation are limited by donor availability.
- Stem cell-based therapies are being explored for cardiac repair and regeneration.
Purpose of the Study:
- To review the current state of fetal and perinatal stem cells for cardiac repair.
- To discuss pathological conditions and therapeutic strategies for heart regeneration.
Main Methods:
- Review of existing literature on fetal and perinatal stem cells.
- Analysis of therapeutic approaches including cell transplantation, paracrine therapy, reprogramming, and tissue engineering.
Main Results:
- Fetal and perinatal stem cells possess significant regenerative capacity and self-renewal capabilities.
- These cells are easily collected from clinical waste materials like amniotic fluid and placenta.
- Various therapeutic strategies are being investigated for their application in cardiac repair.
Conclusions:
- Fetal and perinatal stem cells represent a promising source for developing novel cardiac regenerative therapies.
- Further research into cell transplantation, paracrine effects, reprogramming, and tissue engineering holds potential for treating heart failure.
Abstract:
Efficient cardiac repair and ultimate regeneration still represents one of the main challenges of modern medicine. Indeed, cardiovascular disease can derive from independent conditions upsetting heart structure and performance: myocardial ischemia and infarction (MI), pharmacological cardiotoxicity, and congenital heart defects, just to name a few. All these disorders have profound consequences on cardiac tissue, inducing the onset of heart failure over time. Since the cure is currently represented by heart transplantation, which is extremely difficult due to the shortage of donors, much effort is being dedicated to developing innovative therapeutic strategies based on stem cell exploitation. Among the broad scenario of stem/progenitor cell subpopulations, fetal and perinatal sources, namely amniotic fluid and term placenta, have gained interest due to their peculiar regenerative capacity, high self-renewal capability, and ease of collection from clinical waste material. In this review, we will provide the state-of-the-art on fetal perinatal stem cells for cardiac repair and regeneration. We will discuss different pathological conditions and the main therapeutic strategies proposed, including cell transplantation, putative paracrine therapy, reprogramming, and tissue engineering approaches.
Related Concept Videos
What is Conservation Biology?
Restorative Care
The Tree of Life - Bacteria, Archaea, Eukaryotes
Survival Tree
Building a Survival Tree
Constructing a...
Adult Stem Cells
Phylogenetic Trees

